M1 Kliniken AG has continued its profitable growth in 2018 and invested considerably in further expansion. In the 2018 financial year, the M1 Group increased sales by a good 38% year-on-year to EUR 65.2 million (preliminary figures). Despite the start-up costs of the numerous new locations profit increased in 2018.
M1 Kliniken AG (ISIN: DE000A0STSQ8) is driving growth in the field of medical cosmetic products. Under its own brand M1 SELECT, the beauty medicine specialist has been offering a selected range of high-quality active cosmetics with a focus on skin and facial care since December 2017.
M1 Kliniken AG (ISIN: DE000A0STSQ8) has continued its profitable growth course in 2018 and invested considerably in further growth. As the leading private German provider of health services in the field of beauty medicine, the group of companies benefits from the increasing demand for plastic and aesthetic treatments
M1 Kliniken AG (ISIN: DE000A0STSQ8) has expanded its range of services to include aesthetic laser treatments. They are already offered under the new brand “M1 Laser” at nine locations in Germany. The existing premises of “M1 Med Beauty” are used for this purpose.
M1 Kliniken AG (ISIN: DE000A0STSQ8), market leader in the field of beauty medicine in Germany, has opened the first “M1 Med Beauty” specialist centre outside its home market in Vienna. In the Austrian capital, M1’s experienced specialists are now available for all aspects of aesthetic medicine.
M1 Kliniken AG continues its expansion course in 2018. 4 new specialist centres have been opened so far this year. Two more are to follow by the end of the year. The M1 Group will thus operate a total of 24 specialist centres for aesthetic treatments by the end of 2018.
The Management Board of M1 Kliniken AG today decided to increase the company’s share capital by up to 10% against cash contributions on the basis of the authorization granted by the Annual General Meeting by partially utilizing the authorized capital 2018. The Supervisory Board has approved the decision.
M1 Kliniken AG continued its growth path in the first half of 2018 and increased sales by 30%. As the leading private provider of health services in the field of beauty medicine in Germany, the group is benefiting with its brand “M1 Med Beauty” from the growing demand for plastic and aesthetic treatments.
On growth track with top-class aesthetic medicine: M1 Kliniken AG, leading private provider of health services in the field of beauty medicine in Germany, has again significantly increased its sales and profits in 2017. According to unaudited figures, sales increased by 31.1% to EUR 47.2 million in the previous year.
The demand for plastic and aesthetic beauty treatments in Germany has also risen in 2017. This benefits M1 Kliniken AG, which is the number one in the field of beauty medicine in Germany under its “M1 Med Beauty” brand. In 2017 alone, the number of specialist centres in Germany increased from 11 to 17.
M1 Kliniken AG (ISIN: DE000A0STSQ8, WKN: A0STSQ) has successfully completed the capital increase in accordance with the resolutions passed yesterday and today. The capital increase was oversubscribed several times.
The Management Board of M1 Kliniken AG today resolved to increase the company’s share capital by up to 10% against cash contributions on the basis of the authorization granted by the Annual General Meeting on July 2,2015 with the approval of the Supervisory Board and partially utilizing the authorized capital 2015.
We use cookies on our website.Some of them are essential, while others help us to improve this website and your experience.
Technically necessary tools that enable essential services and basic functions, including identity verification, service continuity and site security. This option cannot be denied.
Schützt vor Cross-Site-Request-Forgery Angriffen.
Speichert die aktuelle PHP-Session.
Third-party content, e.g. stock widgets, are blocked by default. If third-party cookies are accepted, access to this content no longer requires manual consent.
We use the TradingView to display stock charts. This provider uses additional cookies to analyze its services.
By using this website, you consent to the use of cookies. You can find detailed information on the use of cookies on this website in the data protection declaration.
Menu
